FDA Drug Application (009217) for UNITENSEN by MEDPOINTE PHARM HLC

Back to FDA Applications sponsored by MEDPOINTE PHARM HLC

Application Number009217
Product Number001
FormTABLET;ORAL
Dosage260CSR UNIT
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameUNITENSEN
Active IngredientCRYPTENAMINE TANNATES



Back to FDA Applications sponsored by MEDPOINTE PHARM HLC